Characterization of the selected honeybee products based on omics techniques




honeybee products, proteomics, metabolomics, mass spectrometry


to comprehensively characterize honeybee venom, royal jelly, propolis, and pollen, by applying advanced analytical and bioinformatics methodologies. Honeybee products (HBP) contain many bioactive components with both beneficial and harmful effects on the human organism. Nevertheless, the overall composition of the HBP remains not fully investigated. Thus, this research is focused on complementary proteomic and metabolomic characterization of biologically active compounds derived from HBP, regarding their toxicological and pharmacological properties. The objectives of the study will be achieved by the application of up to date mass spectrometry techniques. Due to increasing interest in using of HBP in medicine, this project will contribute to improving the safety of HBP‑derived dietary supplements and drugs.


Download data is not yet available.


Matysiak J, Hajduk J, Mayer F, Hebeler R, Kokot ZJ. Hyphenated LC–MALDI–ToF/ToF and LC–ESI–QToF approach in proteomic characterization of honeybee venom. J Pharm Biomed Anal. 2016;121:69–76.

Matysiak J, Hajduk J, Pietrzak Ł, Schmelzer CEH, Kokot ZJ. Shotgun proteome analysis of honeybee venom using targeted enrichment strategies. Toxicon. 2014;90:255–64.

Matysiak J, Schmelzer CEH, Neubert RHH, Kokot ZJ. Characterization of honeybee venom by MALDI‑TOF and nanoESI‑QqTOF mass spectrometry. J Pharm Biomed Anal. 2011;54(2):273–8.

Kim CMH. Apitherapy — Bee Venom Therapy. In: Grassberger M, Sherman RA, Gileva OS, Kim CMH, Mumcuoglu KY, editors. Biotherapy — History, Principles and Practice. Dordrecht: Springer Netherlands; 2013. p. 77–112.

Sánchez‑Bayo F, Goulson D, Pennacchio F, Nazzi F, Goka K, Desneux N. Are bee diseases linked to pesticides? — A brief review. Environ Int. 2016;89–90:7–11.

Ugur B, Chen K, Bellen HJ. Drosophila tools and assays for the study of human diseases. Dis Model Mech. 2016;9(3):235–44.

Alfa RW, Kim SK. Using Drosophila to discover mechanisms underlying type 2 diabetes. Dis Model Mech. 2016;9(4):365–76.

Tabunoki H, Bono H, Ito K, Yokoyama T. Can the silkworm (Bombyx mori) be used as a human disease model? Drug Discov Ther. 2016;10(1):3–8.

Francese S, Lambardi D, Mastrobuoni G, la Marca G, Moneti G, Turillazzi S. Detection of Honeybee Venom in Envenomed Tissues by Direct MALDI MSI. J Am Soc Mass Spectrom. 2009;20(1):112–23.

Kokot ZJ, Matysiak J, Urbaniak B, Dereziński P. New CZE‑DAD method for honeybee venom analysis and standardization of the product. Anal Bioanal Chem. 2011;399(7):2487–94.

How to Cite

Matuszewska E, Dereziński P, Klupczyńska A, Światły-Błaszkiewicz A, Plewa S, Lubawy J, Urbański A, Rosiński G, Kokot ZJ, Matysiak J. Characterization of the selected honeybee products based on omics techniques. JMS [Internet]. 2019 Jun. 30 [cited 2023 Jun. 3];88(2):129-32. Available from:



The Rationale, Design and Methods of New Studies
Received 2018-11-30
Accepted 2019-02-14
Published 2019-06-30